Launching biomedicine production in AryoGen
has been done with collaboration of several
biological, medical and bioprocess professionals
with a vast spectrum of different specialties.
In our big team, we have benefit of using the
following specialists and experts:
Molecular biologists, Genetic engineers,
Microbiologists, Immunologists, Pharmacists,
Physicians, Chemical engineers, Chemists, Toxicologists,
Statisticians, Nurses and Biochemists.
Continuing this contribution helps patients
get more efficacious and easier health care services.
It is expected that with increasing prescription of AryoGen’s
biomedicines due to increased trust of specialists and patients
to AryoGen products, most healthcare professionals recommend them
as a choice medicine for several disorders.
AryoTrust (Trastuzumab) is produced by hiring recombinant CHO cells as small factories for production of the therapeutical protein.
Biopharmaceutical production applying cutting edge biotechnology practices and manufacturing technology transfer
Increasing the quality and availability of biopharmaceutical products in order to improve quality of life of global community
Achieving the first rank in development, production and export of biopharmaceuticals in the region over the next 5 years
Winning 5% of Iran's market share over the next 5 year